- AIM ImmunoTech flagged a going-concern emphasis-of-matter in audit report included with its audited consolidated financial statements for fiscal 2025.
- Disclosure was made to meet NYSE American Section 610(b) requirements.
- Company stated disclosure does not change or amend its fiscal 2025 SEC filings.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AIM ImmunoTech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604131800PRIMZONEFULLFEED9688936) on April 13, 2026, and is solely responsible for the information contained therein.
Comments